Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study - Concepedia

Concepedia

Publication | Open Access

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

DOI Full Paper Access

100

Citations

21

References

2004

Year

Monika Jermann, L.M. Jost, Ch. Taverna, E Jacky, Hanspeter Honegger, Daniel Betticher, F Egli, Th. Kroner, Rolf A. Stahel

Annals of Oncology

Hematological MalignancyLymphoid NeoplasiaEffective Salvage TherapyMedicineImmunologyPathologyB-cell LymphomasPhase Ii StudyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1